BioNTech SE - ADR

How Aggressive Will the Fed Get in 2022?

Pfizer-BioNTech Ask FDA to Authorize COVID-19 Vaccine for Children 5 to 11

Pfizer, BioNTech To Seek Emergency Use Authorization for COVID-19 Vaccine in Children Under Five

FDA Accelerates Timetable for Final Approval of Pfizer-BioNTech COVID-19 Vaccine

Combination of AstraZeneca’s Vaccine and mRNA Vaccines Found To Be 88% Effective Against COVID-19

Pfizer-BioNTech COVID-19 Vaccine Shows at Least Six Months of Protection in Ongoing Study